Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Purple Biotech Ltd ADR (PPBT)

Purple Biotech Ltd ADR (PPBT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 11,635
  • Shares Outstanding, K 25,238
  • Annual Sales, $ 0 K
  • Annual Income, $ -19,880 K
  • 60-Month Beta 0.94
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 0.30
Trade PPBT with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -1.05
  • Most Recent Earnings $-0.32 on 03/05/24
  • Latest Earnings Date 05/21/24
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Options Overview Details

View History
  • Implied Volatility 778.24% ( -371.33%)
  • Historical Volatility 118.84%
  • IV Percentile 94%
  • IV Rank 51.47%
  • IV High 1,482.05% on 03/19/24
  • IV Low 31.65% on 08/16/23
  • Put/Call Vol Ratio 0.00
  • Today's Volume 19
  • Volume Avg (30-Day) 18
  • Put/Call OI Ratio 0.00
  • Today's Open Interest 1,652
  • Open Int (30-Day) 1,602

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/24
See More
  • Average Estimate -0.15
  • Number of Estimates 1
  • High Estimate -0.15
  • Low Estimate -0.15
  • Prior Year -0.25
  • Growth Rate Est. (year over year) +40.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.3023 +50.51%
on 04/16/24
0.7621 -40.30%
on 04/08/24
-0.2543 (-35.85%)
since 03/19/24
3-Month
0.3023 +50.51%
on 04/16/24
0.9500 -52.11%
on 03/01/24
-0.1950 (-30.00%)
since 01/19/24
52-Week
0.3023 +50.51%
on 04/16/24
2.0984 -78.32%
on 04/26/23
-1.5950 (-77.80%)
since 04/19/23

Most Recent Stories

More News
Purple Biotech Reports Second Quarter 2022 Financial Results

REHOVOT, Israel, Aug. 04, 2022 (GLOBE NEWSWIRE) -- Purple Biotech Ltd. ("Purple Biotech", or the "Company") (NASDAQ/TASE: PPBT), a clinical-stage company...

PPBT : 0.4550 (-1.30%)
Purple Biotech Announces Executive Leadership Changes

Gil Efron appointed as Chief Executive Officer Isaac Israel to transition to advisor role, continue as Board member REHOVOT, Israel, July 14, 2022 ...

PPBT : 0.4550 (-1.30%)
Purple Biotech Presents Phase 1 Interim Monotherapy Data for NT219 at ASCO 2022, Demonstrating Encouraging Safety & Efficacy Profile

A Confirmed Partial Response in GEJ Patient, Stable Disease demonstrated in 75% of patients with mutated-KRAS colon cancer REHOVOT,...

PPBT : 0.4550 (-1.30%)
Purple Biotech Announces the Initiation of Phase 2 Study for CM24 in 2L PDAC Patients

Decision based on positive interim Phase 1b data in pancreatic ductal adenocarcinoma (PDAC)...

PPBT : 0.4550 (-1.30%)
Purple Biotech Reports First Quarter 2022 Financial Results

REHOVOT, Israel, May 12, 2022 (GLOBE NEWSWIRE) -- Purple Biotech Ltd. ("Purple Biotech", or the "Company") (NASDAQ/TASE: PPBT), a clinical-stage company...

PPBT : 0.4550 (-1.30%)
Purple Biotech Presents Positive Interim Phase 1b Study Results for CM24 at the American Association of Cancer Research 2022 Annual Meeting

First-in-class monoclonal antibody in combination with Opdivo® (nivolumab) demonstrates strong safety and an initial efficacy profile for PDAC ...

PPBT : 0.4550 (-1.30%)
Purple Biotech Reports Second Half and Full-Year 2021 Financial Results

REHOVOT, Israel, Feb. 09, 2022 (GLOBE NEWSWIRE) -- Purple Biotech Ltd. ("Purple Biotech", or the "Company") (NASDAQ/TASE: PPBT), a clinical-stage company...

PPBT : 0.4550 (-1.30%)
Purple Biotech Issues Letter to Shareholders

REHOVOT, Israel, Feb. 04, 2022 (GLOBE NEWSWIRE) --   Purple Biotech Ltd. ("Purple Biotech", or the "Company") (NASDAQ/TASE: PPBT), a clinical-stage...

PPBT : 0.4550 (-1.30%)
Purple Biotech Appoints Life Sciences Industry Investor Ori Hershkovitz to its Board of Directors

REHOVOT, Israel, Jan. 06, 2022 (GLOBE NEWSWIRE) -- Purple Biotech Ltd. ("Purple Biotech", or the "Company") (NASDAQ/TASE: PPBT), a clinical-stage...

PPBT : 0.4550 (-1.30%)
Purple Biotech Appoints Senior Business Development Executive Fabien Sebille as Chief Business Officer

REHOVOT, Israel, Dec. 09, 2021 (GLOBE NEWSWIRE) -- Purple Biotech Ltd. ("Purple Biotech", or the "Company") (NASDAQ/TASE: PPBT), a clinical-stage...

PPBT : 0.4550 (-1.30%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Purple Biotech Ltd. is a clinical-stage company focusing on therapies to overcome tumor immune evasion and drug resistance. The Company's oncology pipeline includes NT219 and CM24. Purple Biotech Ltd., formerly known as Kitov Pharma Ltd., is based in TEL AVIV, Israel.

See More

Key Turning Points

3rd Resistance Point 0.5288
2nd Resistance Point 0.5093
1st Resistance Point 0.4822
Last Price 0.4550
1st Support Level 0.4356
2nd Support Level 0.4161
3rd Support Level 0.3890

See More

52-Week High 2.0984
Fibonacci 61.8% 1.4123
Fibonacci 50% 1.2004
Fibonacci 38.2% 0.9884
Last Price 0.4550
52-Week Low 0.3023

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar